2007 Annual Meeting | From Bench to Bedside: Update on Neuromuscular Disease

��ɫ��

2007 Annual Meeting | From Bench to Bedside: Update on Neuromuscular Disease

Date Monday 04/30/07

Time 07:30 PM - 10:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type After-Dinner Seminar

Director(s) Christopher J. Klein, MD, FAAN

Topic(s)

Learning Objectives Participants should become familiar with the current molecular understanding of neuromuscular diseases, with application in the differential diagnosis, workup including genetic testing, and treatment of common and uncommon nerve, muscle, and neuromuscular junction diseases.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician

Event Timeline
07:15 PM - 10:30 PM		Reception
07:30 PM - 08:20 PM		Application of Molecular Biology in Peripheral Neuropathy Christopher J. Klein, MD, FAAN
08:20 PM - 08:30 PM		Discussion
08:30 PM - 09:20 PM		Molecular Basis and Therapy of Muscle Diseases Michael Sinnreich, MD, PhD
09:20 PM - 09:30 PM		Discussion
09:30 PM - 10:20 PM		Neuromuscular Junction Diseases Andrew G. Engel, MD, FAAN
10:20 PM - 10:30 PM		Discussion

Faculty Disclosures
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Andrew G. Engel, MD, FAAN	The institution of Dr. Engel has received research support from NIH.
Michael Sinnreich, MD, PhD	Prof. Sinnreich has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��